Interestingly, when adding these CBT studies in a post-hoc analysis to the main IL-6 meta-analysis (Gazal et al., 2013; Keri et al., 2014), we observed a significant decrease of IL-6 following treatment in MDD patients (online Supplementary Table S6B). Here, IL6 is linked to major depressive disorder.